BRIEF published on 10/10/2024 at 12:27, 1 month 12 days ago Novacyt Closes IT-IS International Subsidiary Amid Market Saturation Financial Impact Intellectual Property Novacyt PCR Market IT-IS Closure
PRESS RELEASE published on 10/10/2024 at 12:22, 1 month 12 days ago Closure of IT-IS International Novacyt announces closure of IT-IS International subsidiary to improve EBITDA. Retains IP for ongoing dispute with Roche Diagnostics. Focus on future growth and cost reduction EBITDA Closure Novacyt IT-IS International IP Dispute
BRIEF published on 10/01/2024 at 13:41, 1 month 21 days ago Novacyt Provides Monthly Update on Liquidity Agreement and Total Voting Rights Shareholders Voting Rights Liquidity Agreement INVEST SECURITIES Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 1 month 21 days ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
BRIEF published on 09/17/2024 at 10:27, 2 months 5 days ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 2 months 5 days ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:22, 2 months 5 days ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
BRIEF published on 09/06/2024 at 11:51, 2 months 16 days ago Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 08/22/2024 at 12:52, 3 months ago Successful VAT recovery for Novacyt Financial Health Regulation Novacyt VAT Recovered DHSC Dispute
BRIEF published on 08/22/2024 at 12:49, 3 months ago Successful VAT reclaim of £12.2 million by Novacyt Financial Settlement Diagnostics Novacyt VAT Reclaim HMRC
Published on 11/22/2024 at 23:55, 9 hours 16 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 41 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 6 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 41 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 15 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 11 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
